Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.91 USD | -1.09% | +0.89% | -7.15% |
05-08 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
05-08 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.15% | 2.87B | |
+7.71% | 115B | |
+12.82% | 107B | |
-13.43% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.82% | 14.26B | |
+33.08% | 12.37B | |
-27.77% | 8.28B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Goldman Sachs Adjusts Denali Therapeutics Price Target to $82 From $99, Maintains Buy Rating